The University’s Innovation Company, UMI3 Ltd, is urging investors to register their interest in the Graphene Flagship programme.
The 10-year 1 billion Euro programme aims to take graphene from academic laboratories and turn the wonder material into products people can use.
As part of the drive, the Flagship has issued a ‘Registration of Interest’ form for those working within the investment community.
Investors who sign for updates via an e-newsletter will be kept informed about graphene developments, applications and events organised by the Flagship.
UMI3 says around 75 investors have signed up to date.
If you would like to register your interest in graphene and receive the Flagship’s e-newsletter, please sign up here http://svy.mk/1LtCgZJ
University of Manchester spin-out Microbiosensor Ltd has been announced winner of the Start-up Award at the Medilink NorthWest Healthcare Business Awards 2016, with fellow spin-out, Manchester Imaging Ltd also receiving recognition as finalists.
Held at the Victoria Warehouse in Manchester on the 22nd February, The Medilink North West Awards celebrates innovation, growth and commercial success of organisations operating in Healthcare Technology and Life Sciences in the North West. As winners of the North West heat, Microbiosensor is automatically nominated for the 2016 National Medilink UK Awards.
Microbiosensor Ltd is developing novel point-of-care medical devices for detecting microbial infection. These devices act as an early warning system for infection and can even diagnose which antibiotics will be most effective in treating an emerging infection. This proprietary technology is inexpensive and robust, providing a clear ‘yes/no’ signal indicating if a clinically relevant level of infection has been reached, thereby enabling earlier intervention than would otherwise be possible.
Dr Curtis Dobson, co-founder, comments: “We are absolutely delighted to receive this award. This success reflects the dramatic progress Microbiosensor Ltd. has made over last 2 to 3 years in translating University research into a tangible product, with the potential to deliver substantial economic and healthcare impacts across Europe. The Award will give the team a further boost as we move forward with our ambitious plans to gain a CE mark for our first product this year.”
Manchester Imaging is an early stage spin-out developing image analysis and diagnostic software for the dental industry. Applications are being designed to identify dental decay and other potential problems earlier, empowering patients to look after their teeth more effectively and saving money for insurance companies and governments by reducing the need for dental restorations and repairs. The recognition comes on the back of recent seed investment by Mercia Fund Management (MFM).
CEO Tony Travers comments: “To be finalists at this stage of the business is a fantastic accolade. Manchester Imaging is to continue development of its core product portfolio, the services of which are a first for the dental care sector. We hope that, by empowering practitioners and patients to better identify potential problems, we will be able to save local services’ and insurers’ money, whilst ensuring that people have healthy teeth and gums right into old age.”
Both companies were spun out of the University by its agent for intellectual property commercialisation, UMIP. Dr Rich Ferrie, Director of Operations, comments: “I’m delighted that Medilink has recognised the potential of two of our portfolio companies. Microbiosensor and Manchester Imaging have bright futures and I am confident that the combination of great technology and strong committed management will lead to commercial success.”
You are invited to this Facilitated workshop…”MMPathIC Industry workshop – a roadmap for collaboration” 7th April 2016, Manchester
Funded by an MRC Proximity to Discovery “Relationship Incubator” Award and the Manchester Molecular Pathology Innovation Centre (MMPathIC, an MRC/ EPSRC Molecular Pathology node), this workshop aims to identify the gaps and barriers to successful collaboration between the key stakeholders (academics, clinicians and industry) in the development of novel molecular pathology tests and in vitro diagnostics.
Whilst the exact programme is still in development, this will be an opportunity to share your expertise, experiences, interests, successes and failures at this workshop/ forum meeting with like-minded individuals. Representatives from the MMPathIC industry founding partners and the British In Vitro Diagnostic Association will also be present.
The workshop will include networking and informal discussion time.
Topics for discussion and input include:
- defining a roadmap for developing new molecular pathology based tests
- regulatory and other hurdles to successful diagnostic development (and how to overcome these through joint working)
- commercial landscape and opportunities for industry/academic collaboration
WHERE: Citylabs, Nelson Street, M13 9NQ
WHEN: 7 April (10:00 until ~17:00)
WHAT: Industry/ academic workshop
If you have any questions, please contact Dr Katherine Boylan (Katherine.email@example.com) or Dr Penny Johnson (Penny.firstname.lastname@example.org)
If you are interested in attending, please register your interest here by Friday 11th March–
We will confirm whether you have a place by Friday 18th March (but ask that you hold the date in the meantime). Due to the nature of the event, participants will have to commit to the whole day.
In Place of War’s co-director Ruth Daniel was one of the finalists in The Entrepreneur of the Year category of the Made in Manchester Awards held at the Hilton Manchester Deansgate Hotel on February 4th. The prestigious awards dinner, attended by over 500 people from the northwest, celebrates the best of Manchester’s young talent in the financial and professional sectors during 2015.
In Place of War (IPOW) is a multi award-winning University of Manchester initiative which helps to build powerful networks, create social change through creativity and demonstrate the value of the arts to public space, public life and public debate. For ten years the project has been helping to mobilise, empower and connect artists and creative communities in sites of war, revolution and conflict.
Ruth Daniel comments: “I am delighted to even have been considered for this award. I am proud to be from the City of Manchester, where I believe people do things differently. I have always followed my ambitions to make a positive change in the world for my work. Being recognised as a finalist in the entrepreneur of the year category with seven other strong entries, is an incredible achievement for me and for the In Place of War team. Getting this sort of recognition validates the work.”
Our work is about giving isolated artists a wider platform to tell their stories of war and help empower communities through creative practise. Turning our research into practise we have developed a range of innovative alternative educational tools, and raised funds to help create new cultural spaces in some of the world’s most challenging places.”
During the past year, IPOW won the Outstanding Aspiring Social Enterprise of the Year category, at the Making a Difference Awards from the University’s Office of Social Responsibility and was also runner-up in The Guardian University Awards for its international work. The project was also awarded a £5000 Do It Award and a further £10000 Scale and Growth Award from UMIP’s Social Enterprise initiative in partnership with UnLtd which was used to help develop the business model.
IPOW has also developed a ground-breaking creative entrepreneurial programme certified by the University and delivered for free to local young people in communities in some of the most under-resourced parts of the world. In these communities with little access to education, offering a free creative entrepreneurial programme with the certification of the University would provide transformative opportunities for up to 5,000 young people in each community every year.
Visit the In Place of War website for more details about the project http://www.inplaceofwar.net/
For further information about the event and winners, please see:
Do you have an interesting translational research idea?
The University of Manchester has been awarded funding in the fourth round of the MRC Confidence in Concept (CiC) scheme. The funds are intended to accelerate the transition from discovery research to translational development by supporting preliminary work or feasibility studies to establish the viability of an approach, before seeking more substantive funding (e.g. from MRC DPFS).
The call is now open for applications via submission of a 1-page Expression of Interest.
Deadline: 10am Friday 11th March 2016.
Further guidance about the call and the application process.
MRC Confidence in Concept (CiC) scheme 2016: Information event 24th February
We are holding an information event for CiC 2016 on 24th Feb, 11am-2pm (including lunch and networking) at the Nowgen Centre to share our experience from the previous rounds of the programme and provide guidance to potential applicants on how to prepare a competitive CiC proposal.
The information event will include an overview of the scheme from an MRC representative, an industry perspective on the programme, a series of brief presentations about previously-funded projects and details about the process for applications this year. The meeting will end with a buffet lunch giving an opportunity for networking and getting one-to-one advice on your CiC proposal ideas from MRC CiC programme representative, panel members, Research Deanery and Business Engagement (NB: one-to-one sessions must be pre-booked by contacting the Research Deanery).
Full details about the event including indicative agenda and event registration.